Terms: = Cervical cancer AND HER1, YOR227W
7 results:
1. A pan-HER-targeted approach for recurrent or late-stage cervical cancer therapy: mechanisms, recent advances, and clinical prospects.
Liu Y; An Q; Zhao X
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4123-4131. PubMed ID: 32373948
[TBL] [Abstract] [Full Text] [Related]
2. Macrophages may promote cancer growth via a GM-CSF/HB-EGF paracrine loop that is enhanced by CXCL12.
Rigo A; Gottardi M; Zamò A; Mauri P; Bonifacio M; Krampera M; Damiani E; Pizzolo G; Vinante F
Mol Cancer; 2010 Oct; 9():273. PubMed ID: 20946648
[TBL] [Abstract] [Full Text] [Related]
3. Measurement of mRNA of 11 biomarkers by RT-PCR to detect lymph node involvement in cervical cancer.
Samouelian V; Revillion F; Alloy N; Lhotellier V; Leblanc E; Peyrat JP
Int J Biol Markers; 2008; 23(2):74-82. PubMed ID: 18629779
[TBL] [Abstract] [Full Text] [Related]
4. The prognostic significance of human epidermal growth factor receptor correlations in squamous cell cervical carcinoma.
Fuchs I; Vorsteher N; Bühler H; Evers K; Sehouli J; Schaller G; Kümmel S
Anticancer Res; 2007; 27(2):959-63. PubMed ID: 17465227
[TBL] [Abstract] [Full Text] [Related]
5. Signaling interactions of rapamycin combined with erlotinib in cervical carcinoma xenografts.
Birle DC; Hedley DW
Mol Cancer Ther; 2006 Oct; 5(10):2494-502. PubMed ID: 17041093
[TBL] [Abstract] [Full Text] [Related]
6. Correlation between human epidermal growth factor receptor family (EGFR, HER2, HER3, HER4), phosphorylated Akt (P-Akt), and clinical outcomes after radiation therapy in carcinoma of the cervix.
Lee CM; Shrieve DC; Zempolich KA; Lee RJ; Hammond E; Handrahan DL; Gaffney DK
Gynecol Oncol; 2005 Nov; 99(2):415-21. PubMed ID: 16157365
[TBL] [Abstract] [Full Text] [Related]
7. Enhanced sensitivity to the her1/epidermal growth factor receptor tyrosine kinase inhibitor erlotinib hydrochloride in chemotherapy-resistant tumor cell lines.
Dai Q; Ling YH; Lia M; Zou YY; Kroog G; Iwata KK; Perez-Soler R
Clin Cancer Res; 2005 Feb; 11(4):1572-8. PubMed ID: 15746062
[TBL] [Abstract] [Full Text] [Related]
